Explore how PBMs negotiate drug costs, serve as middlemen between insurers and drug makers, and why they're vital yet controversial in healthcare.

It’s not just drugmakers reshaping the pharmaceutical sector; distributors are rapidly transforming, too. While most investors and policymakers focus on rising prescription drug prices or ...

It’s not just drugmakers reshaping the pharmaceutical sector; distributors are rapidly transforming, too. While most investors and policymakers focus on rising prescription drug prices or ...

The local pharmacy used to be the default place to fill prescriptions, but like just about everything else, technology is ...

With hundreds of drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions and mitigate financial losses. These include ...

Orphan drug strategies to help 340B health systems achieve more Orphan drugs have been making headlines for decades — not only for bringing new treatment options to patients with rare conditions and ...